Steven Cohen Kala Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $1.19 Million - $2.72 Million	-310,000 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$3.57 - $6.58 $1.11 Million - $2.04 Million	310,000 New	310,000 $1.18 Million
Q2 2019 Aug 14, 2019	SELL	$4.93 - $8.8 $1.54 Million - $2.75 Million	-312,465 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.19 - $8.97 $1.62 Million - $2.8 Million	312,465 New	312,465 $2.58 Million
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $613,000 - $949,000	-50,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $684,000 - $1.16 Million	50,000	50,000 $925,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.85M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.